Suchergebnisse - "Knapper, Steven"

PubPharm (67)

31

The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias

enthalten in: Oncotarget | 2016

von Zabkiewicz, J. | Gilmour, M. | Hills, R. | +5

32

The FLAM regimen : revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia

enthalten in: Haematologica | 2015

von Knapper, S.

CommentOn: Haematologica. 2015 Sep;100(9):1172-9. - PMID 26022709

33

Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis : results of the UK ROBUST Trial

enthalten in: British journal of haematology | 2015

von Mead, A. | Milojkovic, D. | Knapper, S. | +9

34

Response to ruxolitinib in patients with intermediate‐1–, intermediate‐2–, and high‐risk myelofibrosis: results of the UK ROBUST Trial

enthalten in: British journal of haematology | 2015

von Mead, A. | Milojkovic, D. | Knapper, S. | +9

35

Use of JAK inhibitors in the management of myelofibrosis : a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

enthalten in: British journal of haematology | 2014

von Reilly, J. | McMullin, M. | Beer, P. | +11

36

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

enthalten in: Leukemia research | 2014

von Andersen, C. | Bjørn, M. | McMullin, M. | +22

37

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

enthalten in: Leukemia research | 2014

von Andersen, C. | Bjørn, M. | McMullin, M. | +22

38

Elacytarabine in relapsed/refractory acute myeloid leukaemia : an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

39

Elacytarabine in relapsed/refractory acute myeloid leukaemia: An evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

40

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

enthalten in: Blood | 2013

von Burnett, A. | Russell, N. | Hunter, A. | +9